Loading…
Based on limited metadata without access to the full warning letter text, this FDA warning concerns Hospira Healthcare India Pvt. Ltd., a pharmaceutical manufacturer, regarding drug product manufacturing or quality compliance issues. The specific violations cannot be detailed as no subject line information is available in the metadata provided. The warning was issued by the FDA in March 2019 and relates to drug products under FDA jurisdiction. To understand the precise nature of the regulatory concerns and required corrective actions, review of the complete warning letter would be necessary.